| 名稱 | Doxycycline hydrochloride |
| 描述 | Doxycycline hydrochloride (Hyclate) is a synthetic tetracycline derivative with similar antimicrobial activity. |
| 細(xì)胞實(shí)驗(yàn) | Doxycycline is diluted in culture medium at a concentration of 10 μg/mL. All in vitro treatments are performed in SMC cultures at 90% confluence, when ECM synthesis in SMC starts to be evident. Doxycycline (20 nM) is diluted in culture medium at a concentration of 10 μg/mL (20 nM), at which no toxicity or variation in primary cultured SMC proliferation has been reported, as well as in other cell lines and the incubation time is 48 h. SMC-C and SMC-Ch are seeded at equal cell density in 6-well plates and, when confluence reaches 90%, 1 mL culture medium is added to each well containing 3.7×104?Bq L-[5-H3]-proline (9.62×1011 Bq/mmol). After 48?h incubation, cells are lysed with 0.5 mL 0.5 mol/L NaOH for 1 h. The resulting solution is neutralized with an equal amount of 0.5 mol/L HCl, and 50 μL are used to measure total proteins with the Bradford method. One volume of 10% TCA is added to the remaining 250 μL and centrifuged at 13,000 g for 15?min at 4°C. The resulting precipitate is dissolved in 100 μL 0.2 mol/L NaOH, and then neutralized with 1 mol/L HCl. The solution is incubated with collagenase buffer (Tris-HCl, pH 7.6 20 mM, and CaCl2 250 mM final concentration) and 10 units of collagenase at 37°C overnight. Then, 150 μL 10% TCA are added and centrifuged at 13000 g for 15?min at 4°C. The resulting supernatant is added to 4 mL of scintillation fluid and the radioactivity is measured in a liquid scintillation counter LS 600 TA. |
| 激酶實(shí)驗(yàn) | Gelatin (0.1% (w/v) is added to standard LaemmLi acrylamide polymerization mixture. Tissue extract is mixed 1:2 with sample buffer [250 mM Tris-Cl pH 6.8, 10% (w/v) SDS, 20% (v/v) glycerol, 0.005% (w/v) bromphenol blue]. Serum is diluted 1:10 with electrophoresis buffer (2.5 mM Tris, 20 mM glycine, 0.005% SDS) and mixed 1:2 with sample buffer. Twenty μLs are loaded after 10-min incubation at room temperature without boiling. After electrophoresis at 90 V, the gels are soaked in 2.5% (w/v) Triton X-100, incubated 2 to 3 days at 37°C in gelatin digestion buffer [50 mM Tris-Cl, pH 8.0, 8 mM CaCl2, 10 mM ZnSO2, 0.02% (w/v) NaN3], stained in 0.05% Coomassie blue R-250 in acetic acid/methanol/water (1:4.5:4.5 by volume), destained in 10% acetic acid and 5% methanol, and scanned for lysis band intensity. The lysis band intensity is proportional to gelatinase activity and is quantified densitometrically by using One-Dimensional Scan software. The result, a number between 0.07 and 3.75, is normalized to the protein content by dividing the densitometry result with the relative optical density from the BCA protein assay kit result. The result is used for the analysis as the arbitrary unit. For the total MMP activity results of lysis bands of pro-MMP-9, active MMP-9, pro-MMP-2, and active MMP-2 are added. A protein size marker is used to determine the correct size. |
| 體外活性 | 在Wistar大鼠中,每天 Doxycycline（25 mg）能夠阻斷主動(dòng)脈彈性蛋白的結(jié)構(gòu)性惡化,降低動(dòng)脈壁中基質(zhì)金屬蛋白酶MMP-2和MMP-9的活性,從而減少平滑肌細(xì)胞在內(nèi)膜的復(fù)制. |
| 體內(nèi)活性 | 在類風(fēng)濕滑膜成纖維細(xì)胞和內(nèi)皮細(xì)胞中,Doxycycline（50 μM）下調(diào)MMP-8的在mRNA和蛋白水平的表達(dá),同時(shí)完全抑制II型膠原的降解。在角膜上皮細(xì)胞中,Doxycycline抑制脂多糖誘導(dǎo)的IL-1β的mRNA和蛋白的量的增加。 |
| 存儲(chǔ)條件 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 10 mM
|
| 關(guān)鍵字 | Inhibitor | Matrix metalloproteinases | LNT-229 | G55 | inhibit | Doxycycline hydrochloride | Antibiotic | 293T | U343 | MMP | Doxycycline | anti-proliferative activity | Doxycycline Hydrochloride | MCF 12A | Bacterial | antibacterial activity | SVG |
| 相關(guān)產(chǎn)品 | Crystal Violet | Dehydroacetic acid sodium | Doxycycline | Methyl anthranilate | Glucosamine | Neomycin sulfate | Metronidazole | Dimethyl sulfoxide | EDTA copper(II) disodium salt | Ampicillin sodium | Sulfamethoxazole sodium | Kanamycin sulfate |
| 相關(guān)庫(kù) | 抗癌活性化合物庫(kù) | 抗菌活性庫(kù) | 抗癌臨床化合物庫(kù) | 抗癌藥物庫(kù) |